Moxifloxacin hydrochloride injection approved for marketing
-
Last Update: 2020-01-15
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On January 15, Peking University Pharmaceutical announced that the company had received the registration approval of moxifloxacin hydrochloride injection approved and issued by the State Food and drug administration Drug name: moxifloxacin hydrochloride injection English name / Latin name: moxifloxacin hydraulic injection Main ingredients: moxifloxacin hydrochloride Dosage form: injection Specification: 20ml: 0.4g (calculated by c21h24fn3o4) Application items: domestic drug registration Registration classification: Category 5 of original chemicals Drug validity: 12 months Drug approval No.: gyzz h20193431 Validity of drug approval No.: to December 29, 2024 Pharmaceutical manufacturer: Peking University Pharmaceutical Co., Ltd
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
